It is the position of the American Association of Diabetes Educators that diabetes educators should be included as expert consultants for formulary decisions regarding diabetes medications and medical devices.
Get full access to this article
View all access options for this article.
References
1.
HappeLEClarkDHollidayEet al. A systematic literature review assessing the directional impact of managed care formulary restrictions on medication adherence, clinical outcomes, economic outcomes, and health care resource utilization. J Manag Care Spec Pharm. 2014;20(7):677-684.
2.
LotvinAMShrankWHSinghSCet al. Specialty medications: traditional and novel tools can address rising spending on these costly drugs. Health Aff (Millwood). 2014;33(10):1736-1744.
3.
MorelloCMChristopherMLOrtegaLet al. Clinical outcomes associated with a collaborative pharmacist-endocrinologist diabetes intense medical management “tune up” clinic in complex patients. Ann Pharmacother. 2016;50(1):8-16.
4.
LibbyAMFishDNHosokawaPWet al. Patient-level medication regimen complexity across populations with chronic disease. Clin Ther. 2013;35(4):385-398.
5.
PatelBNAudetPR. A review of approaches for the management of specialty pharmaceuticals in the United States. Pharmaco-Economics. 2014;32(11):1105-1114.
American Society of Health-Systems Pharmacists. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. https://www.medscape.com/viewarticle/583780. Accessed July 21, 2016.
8.
NeumannPJCohenJT. Measuring the value of prescription drugs. N Engl J Med. 2015;373(27):2595-2597.
9.
SchommerJCCarlsonAMRheeTG. Validating pharmaceutical product claims: questions a formulary committee should ask. J Med Econ. 2015;18(12):1000-1006.
10.
PetrouPTaliasMA. Navigating through the maze of pricing and affordability of branded pharmaceuticals in the midst of the financial crisis: a comparative study among five European recession countries, from a Cyprus perspective. J Pharm Policy Pract. 2016;9:8.
MorganSHanleyGGreysonD. Comparison of tiered formularies and reference pricing policies: a systematic review. Open Med. 2009;3(3):e131-e139.
13.
MayMSchindlerC. Clinically and pharmacologically relevant interactions of antidiabetic drugs. Ther Adv Endocrinol Metab. 2016;7(2):69-83.
14.
GelladWMorMZhaoXet al. Variation in use of high-cost diabetes mellitus medications in the VA healthcare system. Arch Intern Med. 2012;172(20):1608-1609.
15.
EbyELBoyeKSLageMJ. The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study. J Med Econ. 2013;16(10):1231-1237.
